1. AB0528 Concomitant medication in systemic lupus erythematous (SLE) patients treated with belimumab in clinical practice settings: results from the observe study in switzerland. (12th June 2018) Authors: von Kempis, J.; Dütsch, S.; Reuschling, N.; Schaer, D.; Vallelian, F.; Villiger, R.; Villiger, P.M.; Mueller, R.B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pan-RAF blockade alters intra-tumor immune balance resulting in a CD4+ T cell dominated tumor microenvironment. (December 2016) Authors: Amaladas, N.; Zhao, B.; Chen, S.H.; Huber, L.; Bhagwat, S.; Manro, J.; Doman, T.; Donoho, G.; Hall, G.; Novosiadly, R.; Kalos, M.; Peng, S.B.; Schaer, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗